ANSWERS TO QUESTIONS ABOUT THE ACELLULAR PERTUSSIS-VACCINE

Authors
KIMMEL SR
Citation
Sr. Kimmel, ANSWERS TO QUESTIONS ABOUT THE ACELLULAR PERTUSSIS-VACCINE, American family physician, 47(8), 1993, pp. 1825-1832
Citations number
NO
Categorie Soggetti
Medicine, General & Internal
Journal title
American family physician → ACNP
ISSN journal
0002838X
Volume
47
Issue
8
Year of publication
1993
Pages
1825 - 1832
Database
ISI
SICI code
0002-838X(1993)47:8<1825:ATQATA>2.0.ZU;2-J
Abstract
Two acellular pertussis vaccines, which are usually combined with diph theria and tetanus toxoids, are now licensed for use in the United Sta tes. These vaccines are immunogenic and produce fewer adverse reaction s than whole-cell pertussis vaccines. At present, acellular vaccines a re to be used only for the fourth and fifth booster doses of diphtheri a-tetanus-pertussis vaccine in children 15 months of age or older. Eff icacy of the acellular vaccines in younger children is currently being investigated.